Literature DB >> 2088294

Applications of bioelectrical impedance analysis: a critical review.

H C Lukaski1.   

Abstract

Tetrapolar BIA offers great potential for noninvasive assessment of human body composition because it is safe, portable and easy to use. Additional research is needed in clinical studies among patients in whom body composition and fluid status are impaired. However, appropriate reference methods are required to establish the validity of the BIA method. Critical evaluation of the regional measurement of bioelectrical impedance variables for the assessment of human body composition is needed.

Entities:  

Mesh：

Year:  1990        PMID： 2088294     DOI： 10.1007/978-1-4613-1473-8_51

Source DB:  PubMed          Journal:  Basic Life Sci        ISSN： 0090-5542


  4 in total

Review 1.  Physical methods for evaluating the nutrition status of hemodialysis patients.

Authors:  Daniele Marcelli; Peter Wabel; Sebastian Wieskotten; Annalisa Ciotola; Aileen Grassmann; Attilio Di Benedetto; Bernard Canaud
Journal:  J Nephrol       Date:  2015-03-20       Impact factor: 3.902

2.  Individual theophylline dosing based on bioelectrical impedance analysis.

Authors:  J S Sidhu; E J Triggs; B G Charles; B A Smithurst
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

3.  Developing and Validating an Age-Independent Equation Using Multi-Frequency Bioelectrical Impedance Analysis for Estimation of Appendicular Skeletal Muscle Mass and Establishing a Cutoff for Sarcopenia.

Authors:  Yosuke Yamada; Miyuki Nishizawa; Tomoka Uchiyama; Yasuhiro Kasahara; Mikio Shindo; Motohiko Miyachi; Shigeho Tanaka
Journal:  Int J Environ Res Public Health       Date:  2017-07-19       Impact factor: 3.390

4.  Bioelectrical impedance vector analysis (BIVA) in sport and exercise: Systematic review and future perspectives.

Authors:  Jorge Castizo-Olier; Alfredo Irurtia; Monèm Jemni; Marta Carrasco-Marginet; Raúl Fernández-García; Ferran A Rodríguez
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.